China Resources Sanjiu Medical & Pharmaceutical (000999) Key Financial Indicators

28.34
+0.04+0.14%

Market Closed Jan 23 15:00 CST

47.16BMarket Cap17.08P/E (TTM)

000999 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of China Resources Sanjiu Medical & Pharmaceutical shows that the company's current ratio is 1.83, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

000999 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of China Resources Sanjiu Medical & Pharmaceutical, the quick ratio is 1.39, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

000999 Return on Equity (ROE)

Want to learn more about the financial health of China Resources Sanjiu Medical & Pharmaceutical? The latest ROE figure is 11.47%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

000999 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of China Resources Sanjiu Medical & Pharmaceutical, the total asset return on investment (ROA) is 6.00%.

Currency: CNY

Cumulative Quarterly

000999 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check China Resources Sanjiu Medical & Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 53.52%.

Currency: CNY

Cumulative Quarterly

000999 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of China Resources Sanjiu Medical & Pharmaceutical, the net profit margin is 13.19%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More

Futubull Options Sir

Jan 19 17:47

Options Weekly 0119 | Greenland tariff standoff, gold and silver surge again, shocking reversal in Fed chair nominee! Watch Intel, Netflix earnings reports

杨杨得億

Jan 20 13:42

The real danger in the 2026 market isn't black swan events, but rather the changes you've become accustomed to ignoring.